Related references
Note: Only part of the references are listed.Vascular Endothelial Protein Tyrosine Phosphatase Regulates Endothelial Function
Dietmar Vestweber
PHYSIOLOGY (2021)
Oxidative metabolism of razuprotafib (AKB-9778), a sulfamic acid phosphatase inhibitor, in human microsomes and recombinant human CYP2C8 enzyme
Patrick Camilleri et al.
XENOBIOTICA (2021)
Therapeutic targeting of the angiopoietin-TIE pathway
Pipsa Saharinen et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Targeting Tie2 for Treatment of Diabetic Retinopathy and Diabetic Macular Edema
Peter A. Campochiaro et al.
CURRENT DIABETES REPORTS (2016)
Treatment of Diabetic Macular Edema with an Inhibitor of Vascular Endothelial-Protein Tyrosine Phosphatase That Activates Tie2
Peter A. Campochiaro et al.
OPHTHALMOLOGY (2015)
Human Liver Cytochrome P450 Enzymes and Microsomal Thiol Methyltransferase Are Involved in the Stereoselective Formation and Methylation of the Pharmacologically Active Metabolite of Clopidogrel
Cai Liu et al.
DRUG METABOLISM AND DISPOSITION (2015)
Targeting VE-PTP activates TIE2 and stabilizes the ocular vasculature
Jikui Shen et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Multiple Cytochrome P450 Isoforms Are Involved in the Generation of a Pharmacologically Active Thiol Metabolite, whereas Paraoxonase 1 and Carboxylesterase 1 Catalyze the Formation of a Thiol Metabolite Isomer from Ticlopidine
Min-Jung Kim et al.
DRUG METABOLISM AND DISPOSITION (2014)
Metabolism and Disposition of the Thienopyridine Antiplatelet Drugs Ticlopidine, Clopidogrel, and Prasugrel in Humans
Nagy A. Farid et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2010)
The role of the Angiopoietins in vascular morphogenesis
Markus Thomas et al.
ANGIOGENESIS (2009)
The disposition of prasugrel, a novel thienopyridine, in humans
Nagy A. Farid et al.
DRUG METABOLISM AND DISPOSITION (2007)
The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes
A Parkinson et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2004)
The pharmacokinetics of fondaparinux sodium in healthy volunteers
F Donat et al.
CLINICAL PHARMACOKINETICS (2002)
Share Paper
